The optimal dose of nicardipine for enhancement of indirect portography

CardioVascular and Interventional Radiology

Volumn 21, Issue 1, 1998, Pages 17-21

  Inoue, Yutaka ^a   Nakamura, Hironobu ^b   Akaji, Hideyo ^c  

^a Minoo City Hospital   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Nishiyodo Hospital   (Japan)

Author keywords

Arteries, mesenteric; Drugs, effects; Nicardipine, calcium antagonist; Portal vein, flow dynamics; Portography, technology

Indexed keywords

NICARDIPINE;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PORTAL PHLEBOGRAPHY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SUPERIOR MESENTERIC ARTERY;

AGED; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; NICARDIPINE; PORTAL VEIN; PORTOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RETROSPECTIVE STUDIES;

EID: 0031975749     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002709900204     Document Type: Article

References (18)

1. Chung VP, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140:51-58
2. Rosche A, Schimt P, Medina F, Raynaud A, Lacombe P (1982) The value of a portal study in determining the etiology of hepatic masses in the adult. Radiology 143:387-393
3. Buranasiri S, Baum S (1972) The significance of the venous phase of celiac and superior mesenteric arteriography in evaluating pancreatic carcinoma. Radiology 102:11-20
4. Federle M, Clark RA (1979) Mesenteric varices: A source of mesosystemic shunts and gastrointestinal hemorrhage. Gastrointest Radiol 4:331-337
5. Clark RA, Colley DP (1981) Pharmacoangiography: Techniques and clinical uses. Radiographics 1:43-65
6. Redman HC, Reuter SR, Miller WJ (1969) Improvement of superior mesenteric and portal vein visualization with tolazoline. Invest Radiol 4:24-27
7. Widrich WC, Nordahl DL, Robbins AH (1974) Contrast enhancement of the mesenteric and portal veins using intraarterial papaverine. AJR 121:374-379
8. 1 as a pharmacoangiographic agent for arterial portography Radiology 116:207-209
9. 1 to enhance the angiographic visualization of the splanchnic circulation. Radiology 114:281-286
10. Takenaka T, Usuda S, Nomura T, Maeno H, Sado T (1976) Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methy]amino)]-ethyl ester 5-methyl ester hydrochloride (YC-93). Arzneimittelforschung 26:2172-2178
11. Frampton JE, Faulds D (1993) Nicardipine: A review of its pharmacology and therapeutic efficacy in older patients. Drugs Aging 3:165-187
12. 1. Cardiovasc Intervent Radiol 18:92-96
13. Higuchi S, Shiobara Y (1980) Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 6:447-454
14. Friedman J, Zeit RM, Cope C, Bernhard VM (1984) Optimal use of tolazoline in arteriography. AJR 142:817-820
15. Shehadeh Z, Price WE, Jacobson ED (1969) Effects of vasoactive agents on intestinal blood flow and motiliy in the dog. Am J Physiol 216:386-392
16. 1 in hand angiography. AJR 141:1043-1046
17. 1 on penile blood flow by color duplex sonography. Eur Urol 19:49-53
18. 1 effect on human splanchnic circulation at different dose levels. Invest Radiol 17:249-253